SAN ANTONIO–(BUSINESS WIRE)–Apr 18, 2019–Acelity announced today that its affiliate, KCI Holdings, Inc., filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission, relating to a proposed initial public offering of KCI’s common stock. Prior to the effectiveness of the registration statement, there will be a restructuring as a result of which KCI will become the holding company of the businesses currently conducted by Acelity L.P. Inc. and its subsidiaries. The number of shares to be offered and the price range for the proposed offering have not yet been determined.

J.P. Morgan, Goldman Sachs & Co. LLC and BofA Merrill Lynch are acting as joint book-running managers for the proposed offering.

About Acelity

Acelity L.P. Inc. is a global medical technology company focused on advanced wound care and specialty surgical applications marketed under the KCI brand. The KCI product portfolio is available in more than 90 countries. Headquartered in San Antonio, Texas, Acelity employs nearly 5,000 people around the world.